Musculoskeletal Diseases Treatment Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Musculoskeletal Diseases Treatment Market to 2025 - Global Analysis and Forecasts by Disease (Arthritis, Osteoarthritis, Osteoporosis, Spondylitis, and Others); Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Others) and Geography

Publication Month: Sep 2018 | Report Code: TIPMD00002090 | No. of Pages: 148 | Category: Medical Device | Status: Published

The global musculoskeletal diseases treatment market is expected to reach US$ 5,730.8 Mn in 2025 from US$ 3,837.9 in 2017. The musculoskeletal diseases treatment market is estimated to grow with a CAGR of 5.3% from 2018-2025.

 

North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant rate in Asia Pacific (APAC) region during the forecast period. It is expected that major chunk of the demand is expected to generate from the above mentioned countries. Additionally, factors such as increasing focus of global industry players in India and Japan, funds in China are likely to propel growth of the market.

 

Exhibit: Lucrative Regional Markets

 

Market Insights

Rising Prevalence of Musculoskeletal Disorders

Musculoskeletal disorders are associated with sports, occupational injuries and age-related dysfunction. Some of the most common musculoskeletal diseases are back pain, rheumatoid arthritis, osteoarthritis, osteoporosis, septic arthritis, gout, myasthenia gravis, systemic lupus erythematous (SLE), and others. Musculoskeletal system is the diagnosis and management of all acute and chronic conditions affecting musculoskeletal system, i.e., muscles, bones, tendons, joints and ligaments and treatment of non-surgical lesions of the musculoskeletal system. The rising prevalence of musculoskeletal diseases are the major factors of the market growth. For instance, according to Arthritis Foundation, in 2017, approximately 54 million adults have been diagnosed with arthritis. Almost 300,000 babies and children have arthritis or a rheumatic condition. The common type of arthritis is osteoarthritis, which affects approximately 31 million Americans. By the end of 2040, number of people expected to have doctor-diagnosed arthritis will be above 78 million. As per the report published in 2018 of Healthline Media, rheumatoid arthritis (RA) affects 41 in every 100,000 people per year. Approximately, 1.3 million Americans have RA. Women are about two to three times more likely to get RA than men. The lifetime risk of developing RA is 3.6% for women and 1.7% for men. However, RA can strike at any age even small children can get it. Smoking is the mostly associated risk factor when it comes to the onset of RA in patients. A history of smoking is said to increase the risk of developing RA by as much 2.4%.

 

Technological Advancements in Musculoskeletal Disease Diagnosis

Musculoskeletal diseases treatment is performed with the help of most flexible diagnostic imaging modalities that has capabilities to characterize a wide range of parameters in the living subject as well as provide an exquisite spatial resolution. This technique has been explored by the numerous market players to achieve remarkable precision through extensive innovation in the product design and features. Various recent technological developments are marked in the evolution of musculoskeletal diseases treatment techniques over the past few years.

 

For instance, in June 2018, Konica Minolta Healthcare Americas, Inc., launched the SONIMAGE MX1 portable ultrasound system, developed for musculoskeletal (MSK) and orthopedic practices, interventional guidance and outpatient centers. SONIMAGE MX1 is made with power, portability that physicians need to make a confident and efficient diagnosis at the point-of-care. In March 2018, Philips introduced a new 3-tesla MRI scanner named Ingenia Elition 3.0T at the ECR 2018 in Vienna. Thus, the innovative steps and technological advancements undertaken by new entrants as well as established market players to improve the quality and efficacy of musculoskeletal diseases treatment scans is expected to favor the growth of the market in the years to come.

 

Disease Insights

The musculoskeletal disease treatment market by disease is segmented into arthritis, osteoarthritis, osteoporosis, spondylitis and others. In 2017, the arthritis segment held a largest market share of 43.2% of the musculoskeletal diseases treatment market, by disease. This segment is also expected to dominate the market in 2025 owing to The arthritis is the largest segment among the disease segment in the musculoskeletal diseases treatment market in 2017 and is also anticipated to hold the largest market in the year 2025 owing to the increasing prevalence of the disease across the globe. Furthermore, the spondylitis segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

 

Imaging Modality Insights

On the basis of distribution channel, the musculoskeletal disease treatment market is segmented into computed tomography, magnetic resonance imaging, ultrasound and others. The computed tomography segment is anticipated to grow at a CAGR of 5.4% during the forecast period. The growth of computed tomography segment is primarily driven by increasing product innovation in the field of CT by the market players as well as advances in CT scanning providing increased patient comfort. On the other side, the ultrasound is expected to witness fastest growth registering the CAGR of 5.7% in the global musculoskeletal diseases treatment market over the forecast period.

 

Exhibit: Musculoskeletal dise ase treatment Market, by Imaging Modality

 

Strategic Insights

Product launch/update and agreements & partnerships were observed as the most adopted strategy in global musculoskeletal disease treatment industry. Few of the product approvals and partnerships made by the players in the market are listed below;

 

2018: In Spetember, Royal Philips launched the Ingenia Ambition X 1.5T MR. The product is the latest advance in the Ingenia MRI portfolio, that comprises fully-digital MRI systems, healthcare informatics and a range  of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis.

 

2017: In November, Canon Medical Systems announced the launch of the new package for its iSeries scanners. The series will include Aplio i700, i800, and i900 which will be assessing the patients suffering from diseases.

 

2018: In January, AllTech Medical Systems America and RSTI signed an agreement to provide training. The agreement focusses RSTI offering an MRI service training program at Alltech Medical Systems America’s headquarters in Solon, Ohio. The program is to provide complete spectrum of service solutions and MRI training courses.

MUSCULOSKELETAL DISEASE TREATMENT – MARKET SEGMENTATION

By Disease

  • Arthritis
  • Osteoarthritis
  • Osteoporosis
  • Spondylitis
  • Others

By Imaging Modality

  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Ultrasound
  • Others

By Geography

•   North America

  • U.S.
  • Canada
  • Mexico

•   Europe

  • France
  • Germany
  • UK

•   Asia Pacific (APAC)

  • China
  • India
  • Japan

•   Middle East & Africa (MEA)

  • Saudi Arabia
  • South Africa
  • UAE

•   South America (SAM)

  • Brazil

 

Company Profiles

  • General Electric
  • Siemens AG
  • CANON MEDICAL SYSTEMS CORPORATION
  • Koninklijke Philips N.V.
  • Hitachi, Ltd.
  • Accuray Incorporated
  • MR Solutions
  • Alltech Medical Systems
  • Terason Division Teratech Corporation
  • Echo-Son SA

TABLE OF CONTENTS

1. INTRODUCTION 19
1.1 SCOPE OF THE STUDY 19
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 19

2. GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET – KEY TAKEAWAYS 21

3. GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET – MARKET LANDSCAPE 23
3.1 OVERVIEW 23
3.2 MARKET SEGMENTATION 23
3.2.1 Global Musculoskeletal Diseases Treatment Market – By Disease 24
3.2.2 Global Musculoskeletal Diseases Treatment Market – By Imaging Modality 24
3.2.3 Global Musculoskeletal Diseases Treatment Market – By Geography 25
3.3 PEST ANALYSIS 26
3.3.1 North America – PEST Analysis 26
3.3.2 Europe– PEST Analysis 28
3.3.3 Asia Pacific– PEST Analysis 30
3.3.4 Middle East and Africa – PEST Analysis 32
3.3.5 South and Central America – PEST Analysis 34

4. GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET – KEY MARKET DYNAMICS 36
4.1 KEY MARKET DRIVERS 36
4.1.1 Rising Prevalence of Musculoskeletal Disorders 36
4.1.2 Increasing Elderly Population 37
4.1.3 Technological Advancements in Musculoskeletal Disease Diagnosis 37
4.2 KEY MARKET RESTRAINTS 38
4.2.1 High Costs of Diagnostic Systems 38
4.2.2 Non-existence of Skilled Professionals 39
4.3 KEY MARKET OPPORTUNITIES 39
4.3.1 Development of Hybrid Diagnostic Systems 39
4.3.2 High Market Potential in Developing Nations 40
4.4 FUTURE TRENDS 40
4.4.1 Portable Diagnostic Imaging Systems 40
4.5 IMPACT ANALYSIS 41

5. MUSCULOSKELETAL DISEASES TREATMENT MARKET – GLOBAL ANALYSIS 42
5.1 GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS 42
5.2 GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 43
5.3 PERFORMANCE OF KEY PLAYERS 44
5.4 EXPERT OPINIONS 44

6. GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET ANALYSIS – BY DISEASE 45
6.1 OVERVIEW 45
6.2 GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET, BY DISEASE, 2017 & 2025 (%) 45
6.3 ARTHRITIS MARKET 46
6.3.1 Overview 46
6.3.2 Global Arthritis Market Revenue and Forecasts to 2025 (US$ Mn) 47
6.4 OSTEOARTHRITIS MARKET 48
6.4.1 Overview 48
6.4.2 Global Osteoarthritis Market Revenue and Forecasts to 2025 (US$ Mn) 48
6.5 OSTEOPOROSIS MARKET 49
6.5.1 Overview 49
6.5.2 Global Osteoporosis Market Revenue and Forecasts to 2025 (US$ Mn) 50
6.6 SPONDYLITIS MARKET 51
6.6.1 Overview 51
6.6.2 Global Spondylitis Market Revenue and Forecasts to 2025 (US$ Mn) 51
6.7 OTHERS MARKET 52
6.7.1 Overview 52
6.7.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn) 52

7. GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET ANALYSIS – BY IMAGING MODALITY 53
7.1 OVERVIEW 53
7.2 GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET, BY IMAGING MODALITY, 2017 & 2025 (%) 53
7.3 COMPUTED TOMOGRAPHY (CT) MARKET 54
7.3.1 Overview 54
7.3.2 Global Computed Tomography (CT) Market Revenue and Forecasts to 2025 (US$ Mn) 54
7.4 MAGNETIC RESONANCE IMAGING (MRI) MARKET 55
7.4.1 Overview 55
7.4.2 Global Magnetic Resonance Imaging (MRI) Market Revenue and Forecasts to 2025 (US$ Mn) 55
7.5 ULTRASOUND MARKET 56
7.5.1 Overview 56
7.5.2 Global Ultrasound Market Revenue and Forecasts to 2025 (US$ Mn) 56
7.6 OTHERS MARKET 57
7.6.1 Overview 57
7.6.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn) 57

8. NORTH AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 58
8.1 OVERVIEW 58
8.2 NORTH AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
8.3 NORTH AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS, BY DISEASE (US$ MN) 59
8.4 NORTH AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS, BY IMAGING MODALITY (US$ MN) 60
8.5 NORTH AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 60
8.6 US MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
8.6.1 US Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Disease (US$ Mn) 62
8.6.2 US Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Imaging Modality (US$ Mn) 63
8.7 CANADA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
8.7.1 Canada Musculoskeletal Diseases Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 65
8.7.2 Canada Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Disease (US$ Mn) 65
8.7.3 Canada Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Imaging Modality (US$ Mn) 66
8.8 MEXICO MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
8.8.1 Mexico Musculoskeletal Diseases Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 67
8.8.2 Mexico Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Disease (US$ Mn) 68
8.8.3 Mexico Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Imaging Modality (US$ Mn) 68

9. EUROPE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 69
9.1 OVERVIEW 69
9.2 EUROPE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
9.3 EUROPE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS, BY DISEASE (US$ MN) 70
9.4 EUROPE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS, BY IMAGING MODALITY (US$ MN) 71
9.5 EUROPE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 71
9.6 GERMANY MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 72
9.6.1 Germany Musculoskeletal Diseases Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 73
9.6.2 Germany Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Disease (US$ Mn) 73
9.6.3 Germany Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Imaging Modality (US$ Mn) 74
9.7 UK MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75
9.7.1 UK Musculoskeletal Diseases Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 76
9.7.2 UK Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Disease (US$ Mn) 76
9.7.3 UK Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Imaging Modality (US$ Mn) 77
9.8 FRANCE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
9.8.1 France Musculoskeletal Diseases Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 79
9.8.2 France Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Disease (US$ Mn) 79
9.8.3 France Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Imaging Modality (US$ Mn) 80

10. ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 81
10.1 OVERVIEW 81
10.2 ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 82
10.3 ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS, BY DISEASE (US$ MN) 82
10.4 ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS, BY IMAGING MODALITY (US$ MN) 83
10.5 ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 83
10.6 JAPAN MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 84
10.6.1 Japan Musculoskeletal Diseases Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 85
10.6.2 Japan Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Disease (US$ Mn) 85
10.6.3 Japan Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Imaging Modality (US$ Mn) 86
10.7 CHINA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 87
10.7.1 China Musculoskeletal Diseases Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 88
10.7.2 China Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Disease (US$ Mn) 88
10.7.3 China Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Imaging Modality (US$ Mn) 89
10.8 INDIA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 90
10.8.1 India Musculoskeletal Diseases Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 91
10.8.2 India Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Disease (US$ Mn) 91
10.8.3 India Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Imaging Modality (US$ Mn) 92

11. MIDDLE EAST AND AFRICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 93
11.1 OVERVIEW 93
11.2 MIDDLE EAST AND AFRICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 94
11.3 MIDDLE EAST AND AFRICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS, BY DISEASE (US$ MN) 94
11.4 MIDDLE EAST AND AFRICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS, BY IMAGING MODALITY (US$ MN) 95
11.5 MIDDLE EAST AND AFRICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 95
11.6 UAE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
11.6.1 UAE Musculoskeletal Diseases Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 97
11.6.2 UAE Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Disease (US$ Mn) 97
11.6.3 UAE Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Imaging Modality (US$ Mn) 98
11.7 SAUDI ARABIA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
11.7.1 Saudi Arabia Musculoskeletal Diseases Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 99
11.7.2 Saudi Arabia Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Disease (US$ Mn) 100
11.7.3 Saudi Arabia Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Imaging Modality (US$ Mn) 100
11.8 SOUTH AFRICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
11.8.1 South Africa Musculoskeletal Diseases Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 101
11.8.2 South Africa Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Disease (US$ Mn) 102
11.8.3 South Africa Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Imaging Modality (US$ Mn) 102

12. SOUTH AND CENTRAL AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 103
12.1 OVERVIEW 103
12.2 SOUTH AND CENTRAL AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 104
12.3 SOUTH AND CENTRAL AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS, BY DISEASE (US$ MN) 104
12.4 SOUTH AND CENTRAL AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS, BY IMAGING MODALITY (US$ MN) 105
12.5 SOUTH AND CENTRAL AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 105
12.6 BRAZIL MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 106
12.6.1 Brazil Musculoskeletal Diseases Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 106
12.6.2 Brazil Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Disease (US$ Mn) 107
12.6.3 Brazil Musculoskeletal Diseases Treatment Market Revenue and Forecasts, By Imaging Modality (US$ Mn) 107

13. MUSCULOSKELETAL DISEASES TREATMENT MARKET –INDUSTRY LANDSCAPE 108
13.1 OVERVIEW 108
13.2 GROWTH STRATEGIES IN THE MUSCULOSKELETAL DISEASES TREATMENT MARKET, 2016-2018 108
13.3 ORGANIC DEVELOPMENTS 108
13.3.1 Overview 108
13.4 ORGANIC GROWTH STRATEGIES IN THE MUSCULOSKELETAL DISEASES TREATMENT MARKET, 2016-2018 109
13.5 PRODUCT LAUNCH 109
13.5.1 Recent Product Launch By Players In The Musculoskeletal Diseases Treatment Market 109
13.6 PRODUCT APPROVAL 110
13.6.1 Recent Product Approval By Players In The Musculoskeletal Diseases Treatment Market 110
13.7 PRODUCT UP GRADATION 110
13.7.1 Recent Product Up gradation By Players In The Musculoskeletal Diseases Treatment Market 110
13.8 EXPANSION 111
13.8.1 The Musculoskeletal Diseases Treatment Market By Expansion 111
13.9 INORGANIC DEVELOPMENTS 111
13.9.1 Overview 111
13.10 INORGANIC GROWTH STRATEGIES IN THE MUSCULOSKELETAL DISEASES TREATMENT MARKET, 2015-2018 111
13.11 AGREEMENTS 112
13.11.1 The Musculoskeletal Diseases Treatment Market By Agreements 112
13.12 PARTNERSHIPS 112
13.12.1 Recent Partnership by Players in the Musculoskeletal Diseases Treatment Market 112
13.13 COLLABORATIONS 113
13.13.1 Collaborations By Players In The Musculoskeletal Diseases Treatment Market 113

14. MUSCULOSKELETAL DISEASES TREATMENTMARKET –KEY COMPANY PROFILES 114
14.1 GENERAL ELECTRIC 114
14.1.1 Key Facts 114
14.1.2 Business Description 114
14.1.3 Financial Overview 115
14.1.4 Product Portfolio 115
14.1.5 Swot Analysis 116
14.1.6 Key Developments 116
14.2 KONINKLIJKE PHILIPS N.V. 117
14.2.1 Key Facts 117
14.2.2 Business Description 117
14.2.3 Financial Overview 118
14.2.4 Product Portfolio 118
14.2.5 SWOT Analysis 119
14.2.6 Key Developments 119
14.3 SIEMENS AG 120
14.3.1 Key Facts 120
14.3.2 Business Description 120
14.3.3 Financial Overview 121
14.3.4 Product Portfolio 121
14.3.5 Swot Analysis 122
14.3.6 Key Developments 122
14.4 CANON MEDICAL SYSTEMS CORPORATION 123
14.4.1 Key Facts 123
14.4.2 Business Description 123
14.4.3 Financial Overview 124
14.4.4 Product Portfolio 124
14.4.5 Swot Analysis 125
14.4.6 Key Developments 125
14.5 HITACHI, LTD 127
14.5.1 Key Facts 127
14.5.2 Business Description 127
14.5.3 Financial Overview 127
14.5.4 Product Portfolio 128
14.5.5 Swot Analysis 128
14.5.6 Key Developments 129
14.6 ACCURAY INCORPORATED 130
14.6.1 Key Facts 130
14.6.2 Business Description 130
14.6.3 Financial Overview 131
14.6.4 Product Portfolio 131
14.6.5 SWOT Analysis 131
14.6.6 Key Developments 132
14.7 MR SOLUTIONS 133
14.7.1 Key Facts 133
14.7.2 Business Description 133
14.7.3 Financial Overview 133
14.7.4 Product Portfolio 133
14.7.5 Swot Analysis 134
14.7.6 Key Developments 134
14.8 ALLTECH MEDICAL SYSTEMS 135
14.8.1 Key Facts 135
14.8.2 Business Description 135
14.8.3 Financial Overview 135
14.8.4 Product Portfolio 135
14.8.5 Swot Analysis 136
14.8.6 Key Developments 136
14.9 TERASON DIVISION TERATECH CORPORATION 137
14.9.1 Key Facts 137
14.9.2 Business Description 137
14.9.3 Financial Overview 137
14.9.4 Product Portfolio 137
14.9.5 Swot Analysis 138
14.9.6 Key Developments 138
14.10 ECHO-SON SA 139
14.10.1 Key Facts 139
14.10.2 Business Description 139
14.10.3 Financial Overview 139
14.10.4 Product Portfolio 139
14.10.5 Swot Analysis 140
14.10.6 Key Developments 140
15. APPENDIX 141
15.1 ABOUT THE INSIGHT PARTNERS 141
15.2 GLOSSARY OF TERMS 141
15.3 METHODOLOGY 144
15.3.1 Coverage 145
15.3.2 Secondary Research 145
15.3.3 Primary Research 146

LIST OF TABLES

TABLE 1. NORTH AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 59
TABLE 2. NORTH AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 60
TABLE 3. US MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
TABLE 4. US MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 62
TABLE 5. US MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 63
TABLE 6. CANADA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 65
TABLE 7. CANADA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 66
TABLE 8. MEXICO MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 68
TABLE 9. MEXICO MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 68
TABLE 10. EUROPE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 70
TABLE 11. EUROPE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 71
TABLE 12. GERMANY MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 73
TABLE 13. GERMANY MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 74
TABLE 14. UK MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 76
TABLE 15. UK MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 77
TABLE 16. FRANCE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 79
TABLE 17. FRANCE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 80
TABLE 18. ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 82
TABLE 19. ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 83
TABLE 20. JAPAN MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 85
TABLE 21. JAPAN MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 86
TABLE 22. CHINA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 88
TABLE 23. CHINA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 89
TABLE 24. INDIA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 91
TABLE 25. INDIA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 92
TABLE 26. MIDDLE EAST AND AFRICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 94
TABLE 27. MIDDLE EAST AND AFRICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 95
TABLE 28. UAE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 97
TABLE 29. UAE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 98
TABLE 30. SAUDI ARABIA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 100
TABLE 31. SAUDI ARABIA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 100
TABLE 32. SOUTH AFRICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 102
TABLE 33. SOUTH AFRICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 102
TABLE 34. SOUTH AND CENTRAL AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 104
TABLE 35. SOUTH AND CENTRAL AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 105
TABLE 36. BRAZIL MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 107
TABLE 37. BRAZIL MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 107
TABLE 38. RECENT PRODUCT LAUNCH IN THE MUSCULOSKELETAL DISEASES TREATMENT MARKET 109
TABLE 39. RECENT PRODUCT APPROVAL IN THE MUSCULOSKELETAL DISEASES TREATMENT MARKET 110
TABLE 40. RECENT PRODUCT UP GRADATION IN THE MUSCULOSKELETAL DISEASES TREATMENT MARKET 110
TABLE 41. THE MUSCULOSKELETAL DISEASES TREATMENT MARKET BY EXPANSION 111
TABLE 42. THE MUSCULOSKELETAL DISEASES TREATMENT MARKET BY AGREEMENTS 112
TABLE 43. RECENT PARTNERSHIP IN THE MUSCULOSKELETAL DISEASES TREATMENT MARKET 112
TABLE 44. COLLABORATIONS IN THE MUSCULOSKELETAL DISEASES TREATMENT MARKET 113
TABLE 45. GLOSSARY OF TERMS, MUSCULOSKELETAL DISEASES TREATMENT MARKET 141

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025 21
FIGURE 2. GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET BY DISEASE, MARKET SHARE (%), 2017 22
FIGURE 3. GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET BY IMAGING MODALITY, MARKET SHARE (%), 2017 22
FIGURE 4. MUSCULOSKELETAL DISEASES TREATMENT MARKET SEGMENTATION 23
FIGURE 5. MUSCULOSKELETAL DISEASES TREATMENT MARKET SEGMENTATION, BY REGION 24
FIGURE 6. NORTH AMERICA PEST ANALYSIS 26
FIGURE 7. EUROPE PEST ANALYSIS 28
FIGURE 8. ASIA PACIFIC PEST ANALYSIS 30
FIGURE 9. MIDDLE EAST AND AFRICA PEST ANALYSIS 32
FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS 34
FIGURE 11. MUSCULOSKELETAL DISEASES TREATMENT MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 41
FIGURE 12. GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET – REVENUE FORECASTS AND ANALYSIS – 2017- 2025 42
FIGURE 13. GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2017- 2025 43
FIGURE 14. GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET BY DISEASE, 2017 & 2025 (%) 45
FIGURE 15. GLOBAL ARTHRITIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47
FIGURE 16. GLOBAL OSTEOARTHRITIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
FIGURE 17. GLOBAL OSTEOPOROSIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
FIGURE 18. GLOBAL SPONDYLITIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
FIGURE 19. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
FIGURE 20. GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET SHARE BY IMAGING MODALITY, 2017 & 2025 (%) 53
FIGURE 21. GLOBAL COMPUTED TOMOGRAPHY (CT) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 22. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
FIGURE 23. GLOBAL ULTRASOUND MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
FIGURE 24. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
FIGURE 25. NORTH AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 58
FIGURE 26. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
FIGURE 27. NORTH AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 60
FIGURE 28. US MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
FIGURE 29. CANADA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 65
FIGURE 30. MEXICO MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
FIGURE 31. EUROPE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 69
FIGURE 32. EUROPE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
FIGURE 33. EUROPE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 71
FIGURE 34. GERMANY MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
FIGURE 35. UK MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
FIGURE 36. FRANCE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
FIGURE 37. ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 81
FIGURE 38. ASIA PACIFIC MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 82
FIGURE 39. ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 83
FIGURE 40. JAPAN MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 85
FIGURE 41. CHINA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
FIGURE 42. INDIA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91
FIGURE 43. MIDDLE EAST AND AFRICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 93
FIGURE 44. MIDDLE EAST AND AFRICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 94
FIGURE 45. MIDDLE EAST AND AFRICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 95
FIGURE 46. UAE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 97
FIGURE 47. SAUDI ARABIA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
FIGURE 48. SOUTH AFRICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
FIGURE 49. SOUTH AND CENTRAL AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 103
FIGURE 50. SOUTH AND CENTRAL AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 104
FIGURE 51. SOUTH AND CENTRAL AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 105
FIGURE 52. BRAZIL MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 106
FIGURE 53. GROWTH STRATEGIES IN THE MUSCULOSKELETAL DISEASES TREATMENT MARKET, 2016-2018 108
FIGURE 54. ORGANIC GROWTH STRATEGIES IN THE MUSCULOSKELETAL DISEASES TREATMENT MARKET, 2016-2018 109
FIGURE 55. INORGANIC DEVELOPMENTS IN THE MUSCULOSKELETAL DISEASES TREATMENT MARKET, 2015-2018 111

The List of Companies

1. General Electric
2. Koninklijke Philips N.V.
3. Siemens AG
4. Canon Medical Systems Corporation
5. Hitachi, Ltd.
6. Accuray Incorporated
7. MR Solutions
8. Alltech Medical Systems
9. Terason Division Teratech Corporation
10. Echo-Son SA
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the musculoskeletal diseases treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global musculoskeletal diseases treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution